Skip to content
value.today

Moderna, Inc. vs SynAct Pharma AB

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $31 M for SynAct Pharma AB, 2908 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for SynAct Pharma AB). SynAct Pharma AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $2.8 B for Moderna, Inc. and $11 M for SynAct Pharma AB.

Market value, the same start = 100

From Dec 2022: how each one's value moved, whatever its size.

02959881182023202420252026Moderna, Inc. 118SynAct Pharma AB 13

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Moderna, Inc. $2BSynAct Pharma AB $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureModerna, Inc.
MRNA · #274 in the world
SynAct Pharma AB
SYNACT.ST
Profile
Country🇺🇸 USA🇸🇪 Sweden
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded2010—
Size
Market cap$90.1 B$31 M*
Revenue$1.9 B$0 M
Net income$-2.8 B$-11 M▲ best
Employees4,700—
Valuation
Price to sales35.7×—
Price to book10.4×—
Free cash flow yield-2.3%—
Profitability
Gross margin55.4%—
Operating margin-158.1%—
Net margin-145.2%—
Return on equity-28.9%▲ best-59.5%
Growth
Revenue growth-39.9%—
Revenue growth, 3 years a year-53.4%—
Financial strength
Debt to equity0.1×—
Cash
Free cash flow margin-106.2%—
Shareholder returns
Shareholder yield0.0%—
Strength scores
Piotroski F-score3 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Moderna, Inc. or SynAct Pharma AB?

Moderna, Inc. is the larger company by market value: $90.1 B against $31 M for SynAct Pharma AB, 2908 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for SynAct Pharma AB). SynAct Pharma AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Moderna, Inc. or SynAct Pharma AB?

Both made a net loss: $2.8 B for Moderna, Inc. and $11 M for SynAct Pharma AB.

Sources#

Every figure on this page comes from these, with the date shown next to it.